{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T09:11:06Z","timestamp":1764493866061},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1097\/mph.0000000000000485","type":"journal-article","created":{"date-parts":[[2015,11,19]],"date-time":"2015-11-19T12:12:02Z","timestamp":1447935122000},"page":"e29-e31","source":"Crossref","is-referenced-by-count":12,"title":["Rituximab-induced Cytokine Storm in the Absence of Overt Lymphoproliferative Disease"],"prefix":"10.1097","volume":"38","author":[{"given":"Mark","family":"Williams","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tasneem","family":"Khalid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise","family":"Bonney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Wynn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-28-20210209","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1146\/annurev.med.55.091902.104249","article-title":"Rituximab: expanding role in therapy for lymphomas and autoimmune diseases.","volume":"55","author":"Rastetter","year":"2004","journal-title":"Annu Rev Med"},{"key":"R2-28-20210209","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1053\/j.seminhematol.2010.01.011","article-title":"Rituximab: mechanism of action.","volume":"47","author":"Weiner","year":"2010","journal-title":"Semin Hematol"},{"key":"R3-28-20210209","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1188\/07.CJON.S1.37-42","article-title":"Cytokine-release syndrome: overview and nursing implications.","volume":"11","author":"Breslin","year":"2007","journal-title":"Clin J Oncol Nurs"},{"key":"R4-28-20210209","first-page":"53","article-title":". Optimizing the use of rituximab for treatment of B-cell non-Hodgkins lymphoma: a benefit-risk update.","volume":"27","author":"Kunkel","year":"2000","journal-title":"Semin Oncol"},{"key":"R5-28-20210209","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000337577","article-title":"Rituximab and cytokine release syndrome.","volume":"5","author":"Kulkarni","year":"2012","journal-title":"Case Rep Oncol"},{"key":"R6-28-20210209","first-page":"69","article-title":". Fatal course after administration of rituximab in a boy with relapsed all: a case report and review of literature.","volume":"91","author":"Seifert","year":"2006","journal-title":"Haematologica"},{"key":"R7-28-20210209","first-page":"1962","article-title":"Fatal cytokine release syndrome with chimeric anti-CD20 monoclonal antibody rituximab in a 71-year-old patient with chronic lymphocytic leukemia.","volume":"17","author":"Lim","year":"1999","journal-title":"J Clin Oncol"},{"key":"R8-28-20210209","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1182\/blood.V94.7.2217.419k02_2217_2224","article-title":". Cytokine-release syndrome in patients with B-cell chronic lymphocytic leukemia and high lymphocyte counts after treatment with an anti-CD20 monoclonal antibody (rituximab, IDEC-C2B8).","volume":"94","author":"Winkler","year":"1999","journal-title":"Blood"},{"key":"R9-28-20210209","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1200\/JCO.1999.17.3.791","article-title":". Rituximab therapy in hematologic malignancy patients with circulating blood tumor cells: association with increased infusion-related side effects and rapid blood tumor clearance.","volume":"17","author":"Byrd","year":"1999","journal-title":"J Clin Oncol"},{"key":"R10-28-20210209","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3324\/haematol.10561","article-title":". Severe pulmonary complications after initial treatment with rituximab for the Asian-variant of intravascular lymphoma.","volume":"92","author":"Wu","year":"2007","journal-title":"Haematologica"},{"key":"R11-28-20210209","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3109\/08916934.2013.838563","article-title":"Preliminary analysis of mortality associated with rituximab use in autoimmune diseases.","volume":"46","author":"Shetty","year":"2013","journal-title":"Autoimmunity"},{"key":"R12-28-20210209","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2165\/11585960-000000000-00000","article-title":"Incidence of infusion-associated reactions with rituximab for treating multiple sclerosis: a retrospective analysis of patients treated at a US centre.","volume":"34","author":"Brown","year":"2011","journal-title":"Drug Saf"},{"key":"R13-28-20210209","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1093\/rheumatology\/keq436","article-title":". Rituximab infusion-related adverse event rates are lower in patients with systemic lupus erythematosus than in those with rheumatoid arthritis.","volume":"50","author":"Conti","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"R14-28-20210209","first-page":"101","article-title":". Safety of rituximab in rheumatoid arthritis.","volume":"62","author":"Covelli","year":"2010","journal-title":"Reumatismo"},{"key":"R15-28-20210209","first-page":"87","article-title":"Rituximab for the treatment of rheumatoid arthritis: an update.","volume":"8","author":"Mok","year":"2014","journal-title":"Drug Des Devel Ther"},{"key":"R16-28-20210209","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1212\/WNL.0000000000000570","article-title":". Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS disease.","volume":"83","author":"Dale","year":"2014","journal-title":"Neurology"},{"key":"R17-28-20210209","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.seizure.2013.04.005","article-title":". Febrile infection-related epilepsy syndrome: a study of 12 patients.","volume":"22","author":"Caraballo","year":"2013","journal-title":"Seizure"},{"key":"R19-28-20210209","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1586\/eci.09.31","article-title":". Monoclonal antibody-induced cytokine-release syndrome.","volume":"5","author":"Bugelski","year":"2009","journal-title":"Expert Rev Clin Immunol"},{"key":"R20-28-20210209","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00262-001-0247-1","article-title":". Binding to CD20 by anti-B1 antibody or F(ab)(2) is sufficient for induction of apoptosis in B-cell lines.","volume":"51","author":"Cardarelli","year":"2002","journal-title":"Cancer Immunol Immunother"},{"key":"R21-28-20210209","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/00007890-199701150-00020","article-title":". Role of polymorphic Fc receptor Fc gammaRIIa in cytokine release and adverse effects of murine IgG1 anti-CD3T cell receptor antibody (WT31).","volume":"63","author":"Tax","year":"1997","journal-title":"Transplantation"},{"key":"R22-28-20210209","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.0300-9475.2004.01441.x","article-title":". Apoptotic effect of rituximab on peripheral blood B cells in rheumatoid arthritis.","volume":"60","author":"Szodoray","year":"2004","journal-title":"Scand J Immunol"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000000485","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:47:53Z","timestamp":1620964073000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00043426-201601000-00028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000000485","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]}}}